Literature DB >> 17046662

A Drosophila model of Alzheimer's disease.

Damian C Crowther1, Richard Page, Dhianjali Chandraratna, David A Lomas.   

Abstract

The development of a model of Alzheimer's disease in Drosophila allows us to identify and dissect pathological pathways using the most powerful genetic tools available to biology. By reconstructing essential steps in Alzheimer's pathology, such as amyloid beta peptide and tau overexpression, we can observe clear and rapid phenotypes that are surrogate markers for human disease. The characterization of progressive phenotypes by immunohistochemistry of the brain combined with longevity, climbing, and pseudopupil assays allows the investigator to generate quantitative data. Phenotypes may be modulated by changes in gene expression as part of a genetic screen or by potential therapeutic compounds.

Entities:  

Mesh:

Year:  2006        PMID: 17046662     DOI: 10.1016/S0076-6879(06)12015-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  24 in total

1.  A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease.

Authors:  Angela Fortner McKoy; Jermont Chen; Trudi Schupbach; Michael H Hecht
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

2.  Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.

Authors:  Ann-Christin Brorsson; Benedetta Bolognesi; Gian Gaetano Tartaglia; Sarah L Shammas; Giorgio Favrin; Ian Watson; David A Lomas; Fabrizio Chiti; Michele Vendruscolo; Christopher M Dobson; Damian C Crowther; Leila M Luheshi
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

3.  Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.

Authors:  Michael J Virata; Robert W Zeller
Journal:  Dis Model Mech       Date:  2010-03-02       Impact factor: 5.758

4.  Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.

Authors:  Gennady A Buznikov; Lyudmila A Nikitina; Frederic J Seidler; Theodore A Slotkin; Vladimir V Bezuglov; Ivan Milosević; Lidija Lazarević; Ljubica Rogac; Sabera Ruzdijić; Ljubisa M Rakić
Journal:  Neurotoxicol Teratol       Date:  2008-05-16       Impact factor: 3.763

5.  Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.

Authors:  Leila M Luheshi; Wolfgang Hoyer; Teresa Pereira de Barros; Iris van Dijk Härd; Ann-Christin Brorsson; Bertil Macao; Cecilia Persson; Damian C Crowther; David A Lomas; Stefan Ståhl; Christopher M Dobson; Torleif Härd
Journal:  PLoS Biol       Date:  2010-03-16       Impact factor: 8.029

6.  Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.

Authors:  Oyinkan Sofola; Fiona Kerr; Iain Rogers; Richard Killick; Hrvoje Augustin; Carina Gandy; Marcus J Allen; John Hardy; Simon Lovestone; Linda Partridge
Journal:  PLoS Genet       Date:  2010-09-02       Impact factor: 5.917

7.  Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.

Authors:  Y X Li; O C M Sibon; P F Dijkers
Journal:  J Neuroinflammation       Date:  2018-09-11       Impact factor: 8.322

8.  Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease.

Authors:  Rita Costa; Elena Speretta; Damian C Crowther; Isabel Cardoso
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

9.  Modeling Alzheimer's disease: from past to future.

Authors:  Claudia Saraceno; Stefano Musardo; Elena Marcello; Silvia Pelucchi; Monica Di Luca
Journal:  Front Pharmacol       Date:  2013-06-19       Impact factor: 5.810

Review 10.  Alzheimer's disease: insights from Drosophila melanogaster models.

Authors:  Aileen Moloney; David B Sattelle; David A Lomas; Damian C Crowther
Journal:  Trends Biochem Sci       Date:  2009-12-25       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.